Medicare Enrolled
Dr. Antonio Mancera, MD
Rheumatology · Laredo, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mancera from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mancera?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mancera
Dr. Antonio Mancera is a rheumatology specialist in Laredo, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Mancera performed 143,131 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Mancera received a total of $34,327 from 30 pharmaceutical and/or device companies across 429 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mancera is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 10% volume in TX
$34,327 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗143,131
Medicare services
Top 10% in TX for rheumatology
Not available
Unique patients (not deduplicated)
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
108,800 | $4 | $18 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
30,375 | $33 | $81 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
549 | $50 | $330 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
471 | $92 | $330 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
446 | $88 | $210 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
377 | $1 | $15 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
274 | $5 | $42 |
| Liver function blood test panel | 271 | $8 | $44 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
270 | $8 | $42 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
261 | $5 | $45 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
169 | $8 | $35 |
| Complete ultrasound scan of joint An ultrasound exam that uses sound waves to create detailed images of a joint. This procedure allows for the visualization of the joint's internal structures. |
147 | $9 | $200 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
132 | $21 | $74 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
109 | $110 | $265 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
88 | $48 | $114 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
87 | $17 | $65 |
| Knee X-ray, 3 views An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures. |
82 | $23 | $81 |
| Foot X-ray, 3+ views An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints. |
66 | $20 | $72 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
47 | $20 | $72 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
36 | $21 | $80 |
| Viscosupplementation injection for joint An injection of hyaluronic acid or a derivative into a joint to provide lubrication and cushioning. |
27 | $57 | $190 |
| X-ray of upper spine, 2-3 views An X-ray imaging test of the upper spine using two to three different angles to visualize the bones and structures. |
17 | $18 | $105 |
| Pelvis X-ray, 1-2 views An X-ray imaging test of the pelvic area using one to two different angles to visualize the bones and joints. |
17 | $14 | $76 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
13 | $10 | $65 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
21.6% high complexity
76.9% medium
1.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$34,327
Total received (2018-2024)
Avg $4,904/year across 7 years
Top 13% in TX for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
429
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,066
2023
$928
2022
$337
2021
$14
2020
$181
2019
$12,903
2018
$17,897
Payments by company (2024)
Amgen Inc.
$491
Janssen Biotech, Inc.
$264
GlaxoSmithKline, LLC.
$249
Aurinia Pharma U.S., Inc.
$173
UCB, Inc.
$173
E.R. Squibb & Sons, L.L.C.
$146
Novartis Pharmaceuticals Corporation
$136
AstraZeneca Pharmaceuticals LP
$107
Lilly USA, LLC
$105
Corcept Therapeutics
$69
ANI Pharmaceuticals, Inc.
$60
PFIZER INC.
$41
ABBVIE INC.
$33
Ferring Pharmaceuticals Inc.
$18
Top 3 companies account for 48.6% of 2024 payments
All-time payments by company (2018-2024) ›
Celgene Corporation
$15,029
AbbVie, Inc.
$11,265
Amgen Inc.
$3,213
UCB, Inc.
$817
Janssen Biotech, Inc.
$665
E.R. Squibb & Sons, L.L.C.
$642
Novartis Pharmaceuticals Corporation
$434
GlaxoSmithKline, LLC.
$335
ABBVIE INC.
$313
Aurinia Pharma U.S., Inc.
$272
AstraZeneca Pharmaceuticals LP
$242
Genentech USA, Inc.
$228
Lilly USA, LLC
$221
PFIZER INC.
$143
ANI Pharmaceuticals, Inc.
$101
Corcept Therapeutics
$69
Mallinckrodt Hospital Products Inc.
$45
Antares Pharma, Inc.
$42
AbbVie Inc.
$40
FIDIA PHARMA USA INC.
$34
ARBOR PHARMACEUTICALS, INC.
$31
Orthogenrx Inc.
$21
Ferring Pharmaceuticals Inc.
$18
GENZYME CORPORATION
$17
Ironwood Pharmaceuticals, Inc
$17
Zyla Life Sciences
$15
Organon LLC
$15
Alexion Pharmaceuticals, Inc.
$14
Horizon Therapeutics plc
$14
Mitsubishi Tanabe Pharma America, Inc.
$14
Top 3 companies account for 86.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · BENLYSTA · Bimzelx · CHANTIX · COSENTYX · Cimzia · DUZALLO · EUFLEXXA · EVENITY · Enbrel · GenVisc 850 · HYALGAN · Horizant · Humira · Hymovis · INFLECTRA · KEVZARA · KRYSTEXXA · Korlym · LUPKYNIS · LYRICA · ORENCIA · Otezla · Otrexup · PURIFIED CORTROPHIN GEL · REMICADE · RENFLEXIS · RINVOQ · Radicava · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · TALTZ · TAVNEOS · TREMFYA · Tavneos · XELJANZ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
1
County median income
$62,506
Nearest hospital to ZIP centroid (approximate)
DOCTORS HOSPITAL OF LAREDO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mancera is a mixed practice specialist, with above-average Medicare volume (top 10% in TX), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mancera experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Mancera performed 108,800 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mancera receive payments from pharmaceutical companies?
Yes. Dr. Mancera received a total of $34,327 from 30 companies across 429 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mancera's costs compare to other rheumatologists in Laredo?
Dr. Mancera's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mancera) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Laredo
Browse rheumatologists in Laredo ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in TX
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in TX
Which TX rheumatologists receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology